跳至主要内容
临床试验/JPRN-UMIN000030037
JPRN-UMIN000030037已完成未知

Histidine-Rich Glycoprotein as a novel severity biomarker for sepsis: application to early treatment - HRG as a novel severity biomarker for sepsis

Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 201 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
201

研究概览

简要总结

Although there was no time x survivors/non-survivors interaction in the time courses of HRG (P=0.34), the main effect of generalized linear mixed models was significant (P<0.001). In a univariate Cox proportional hazards model with each variable as a time-dependent covariate, higher HRG levels were significantly associated with a lower risk of mortality (hazard ratio, 0.85 [95%CI, 0.78-0.92]; P<0.001).

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Pregnancy and Under 20 years old

研究者

发起方
Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

相似试验